期刊文献+

慢病毒介导的稳定表达人GM-CSF、IL-4的EA.hy926细胞株的建立

Construction and Identification of Cell Line to Coexpress GM-CSF and IL-4 Mediated by Lentiviral System
下载PDF
导出
摘要 目的:获得能够稳定表达人粒细胞-巨噬细胞集落刺激因子(GM-CSF)和白细胞介素4(IL-4)的内皮细胞株。方法:构建重组慢病毒表达载体,在293FT细胞中进行病毒的包装,用获得的高滴度慢病毒感染EA.hy926细胞株,建立能够稳定、高效表达hGM-CSF、hIL-4的EA.hy926细胞株。结果:EA.hy926感染效率达90%以上,长期传代后阳性率仍维持在90%以上;实时定量PCR和ELISA方法证实感染后细胞hGM-CSF、hIL-4在mRNA水平的表达分别是未感染细胞的25倍和9946倍,在蛋白水平的表达分别是未感染细胞的145倍和23倍。结论:构建的细胞系可以稳定表达细胞因子GM-CSF、IL-4。 Objective: To establish the EA.hy926 cell line expressing granulocyte-macrophage colony stimulating factor(GM-CSF) and interleukin 4(IL-4) stably mediated by lentiviral system.Methods: The recombinant lentiviral plasmid carrying human GM-CSF and IL-4 was transfected into 293FT cells with lentiviral packaging plasmids.Then the infectious lentiviral was obtained,which infected the EA.hy926 cells.The expression of GM-CSF and IL-4 was assayed by qPCR and ELISA.Results: The GM-CSF and IL-4 expression at mRNA level of infected EA.hy926 cells were 24 and 9946 fold respectively for the FLSC not infected by the lentivirus,and then at the protein level were 145 and 23 fold.Conclusion: The infected EA.hy926 cells can stably express GM-CSF and IL-4.
出处 《生物技术通讯》 CAS 2011年第4期480-483,共4页 Letters in Biotechnology
基金 国家传染病重大专项(2008ZX10106) 北京市病毒性肝炎防治技术支撑体系建设重大专项(D08050700650803)
关键词 树突状细胞 转染 白细胞介素4 粒细胞-巨噬细胞集落刺激因子 dendritic cell transfection interleukin 4 granulocyte-macrophage colony stimulating factor
  • 相关文献

参考文献10

  • 1Roncarolo M G, Levings M K, Traversari C. Antigen bearing immature dendritic cells induce peptide-specifie CD8+ regulatory T ceils in vivo in humans[J]. Blood, 2005,100(1):174-177.
  • 2Kreisel L D, Faries M B. Monocyte-derived dendritic cells: development of a cellular processor for clinical applications [J]. Annu Rev Immunol, 2004,149(16):643-646.
  • 3Schanen B C, Drake D R 3rd. A novel approach for tbe gen- eration of human dendritic cells from blood rnonoeytes in the absence of exogenous factors[J].Immunol Method, 2008(335): 53-64.
  • 4Barbuto J A, Ensina L F, Neves A R, et al. Dendritic cell- tumor cell hybrid vaccination for cancer [J]. Cancer Immunol immunother, 2004,53(12): 1111 - 1118.
  • 5Eseudier B, Chaput N. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trail[J]. Transl Med, 2005,3 (1):10.
  • 6Yu John, Liu G T, Ng Hiushan, et al. A phase I trial of in- tracranial dendritic cell immunotherapy for patients with malig- nant glioma[J]. Neurosurgery, 2006,59(2):485-497.
  • 7Zhang M, Tong H, Guo Z, et al. Splenic stroma drivers mature dendritic cells to differentiate into regulatory dendritic cells [J]. Nat Immunol, 2004,5(11):1124-1133.
  • 8Jiang X X, Zhang Y, Liu B, et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells[J]. Blood, 2005,105(10):4120-4126.
  • 9Broty-Boye D, Pittin-Clemeneeau C. Chemokines and CD40 expression in human fibroblasts[J]. Eur J Immunol, 2000,30(3): 914-919.
  • 10Bedford P A, Todorovic V. Adipose tissue of human omentum is a major source of dendritic cell ,which lose MHC class II and stimulatou function in Crohn's disease[J]. J Leukoc Biol, 2006,80(3):914-919.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部